Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 22,270

Document Document Title
WO/2021/066410A1
The present invention relates to a catalyst for ammoxidation of propylene, a method for preparing same, and a method for ammoxidation of propylene using same. Specifically, provided in one embodiment of the present invention is a catalys...  
WO/2021/057816A1
Disclosed is an aptamer nucleic acid molecule, comprising a complex of the aptamer and a small fluorophore molecule. Also disclosed are a method for detecting RNA, DNA or other target molecules inside or outside a cell by means of using ...  
WO/2021/060698A1
The present invention relates to a fluidized bed reactor. Provided is a fluidized bed reactor arrangement comprising: a fluidized bed reactor in which a catalyst bed is provided; a dust collector which is provided at the top of the fluid...  
WO/2021/054202A1
A fluorine-containing ether compound represented by formula (1). (1): R1-R2-CH2-R3-CH2-R4 (In the formula, R1 represents an organic group having an alicyclic structure and from 3 to 13 carbon atoms; R2 represents a group expressed by for...  
WO/2021/047603A1
The present application provides a compound of formula II and a method for preparing a compound of formula I, i.e., 2-isopropyl-4-methylpyridin-3-amine by using same. The compound of formula I can be applied to synthesis of KRAS inhibito...  
WO/2021/048368A1
A process for manufacturing an aqueous hydrogen peroxide solution comprising the following steps: - hydrogenating a working solution which comprises an alkylanthraquinone and/or tetrahydroalkylanthraquinone and a mixture of a non-polar o...  
WO/2021/048364A1
A process for manufacturing a substituted cyclohexanecarbonitrile said process comprising the following steps: - reacting the corresponding substituted cyclohexanecarboxylic acid with thionyl chloride to make the corresponding acyl chlor...  
WO/2021/048365A1
A process for manufacturing an alkyl substituted cyclohexanecarbonitrile, said process comprising the following steps: - reaction of cyanoisophorone with an organometallic compound comprising an alkyl group in order to transform the keto...  
WO/2021/042411A1
Disclosed are an AKR1C3 inhibitor or a pharmaceutically acceptable salt of same, a preparation method for same, and uses thereof. A structural optimization is performed with a nonsteroidal anti-inflammatory medicament, flurbiprofen, serv...  
WO/2021/045466A1
Provided are a compound represented by chemical formula 1, a photosensitive resin composition including the compound, a photosensitive resin film manufactured using the photosensitive resin composition, and a color filter manufactured us...  
WO/2021/046006A1
Disclosed are novel aromatic enol ethers. The aromatic enol ethers exhibit low volatile organic content and are reactive film-hardening compounds. The aromatic enol ethers are useful in a variety of chemical applications. The aromatic en...  
WO/2021/039843A1
The present invention addresses the problem of providing: a (poly)amine compound which is particularly useful as a material for forming a film for lithography or as a material for forming an optical component; a resin which is obtained u...  
WO/2021/029758A1
The present invention provides a cathode active material for a secondary battery comprising a charge transfer complex in which an electron donor and an electron acceptor are bonded together, wherein the electron donor and the electron ac...  
WO/2021/025036A1
Provided are a 2-cyanoacrylate compound represented by formula (1), and an adhesive composition which comprises the 2-cyanoacrylate compound represented by formula (1). In formula (1), R1 is a divalent linking group having 1 to 20 carbon...  
WO/2021/017996A1
Disclosed in the present invention are a phenylpiperazine quinazoline compound or a pharmaceutically acceptable salt thereof, and a preparation method therefor and the use thereof. Specifically, the phenylpiperazine quinazoline compound ...  
WO/2021/017114A1
A cyclic compound and a use thereof, and an electronic device. The cyclic compound comprises at least compounds represented by formulas 001-011, the cyclic compound has good thermal stability and has a matching LUMO energy level to an ad...  
WO/2021/016280A1
The present disclosure provides certain tricyclic compounds that are Hypoxia Inducible Factor 2α (HIF-2α) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of HIF-2α. Also provided are pharmaceu...  
WO/2020/262648A1
The present invention provides a compound that has an excellent pest-controlling effect and that is represented by formula (I) [in the formula, L represents an oxygen atom or CH2, E represents a C2-C10 chain hydrocarbon group or the like...  
WO/2020/255425A1
This anti-HBV agent contains a compound represented by general formula (I) or a compound represented by general formula (II), or a salt thereof.  
WO/2020/251812A1
Provided is a method of making ethylenediaminetetraacetic acid (EDTA) comprising the steps: (a) providing a reaction mixture (a) comprising ethylenediamine (EDA) and glycolonitrile (GN), wherein reaction mixture (a) comprises 0% to 0.1% ...  
WO/2020/248403A1
Disclosed is a novel method for preparing adiponitrile. According to the method, an adipic acid diester and ammonia gas are used as raw materials, and same are subjected to a catalytic ammonolysis-dehydration reaction to directly prepare...  
WO/2020/246283A1
This oxide catalyst is used in a gas phase contact ammoxidation reaction of propane or isobutene and includes a composite oxide, wherein the composite oxide contains a catalytically active species isolated from the composite oxide using ...  
WO/2020/242931A1
Provided herein are processes for purifying TCH in a feed stream, such as an adiponitrile process stream. The processes include a first separating step of separating the adiponitrile process stream to form a first overhead stream compris...  
WO/2020/235336A1
This compound is represented by formula (1). MaXbYc (1) (In formula (1), M represents a metal other than an alkali metal, X represents -N(SO2F)2, Y represents a coordinating solvent, and a, b, and c are positive numbers.)  
WO/2020/230555A1
A method for forming a carbon-carbon bond, wherein: a reaction is performed by filling a container with a platinum group metal-loaded catalyst and having a starting material liquid permeate through the platinum group metal-loaded catalys...  
WO/2020/228359A1
The present invention relates to the field of organic optoelectronic materials, and disclosed are an organic light-emitting material containing tetraphenylbenzene, preparation, and an application. The organic light-emitting material cont...  
WO/2020/230480A1
The present invention addresses the problem of providing: a polymerizable liquid crystal composition that can undergo uniform vertical alignment without a PI layer being provided, can inhibit occurrence of dropping marks or alignment irr...  
WO/2020/221238A1
Provide an aptamer nucleic acid molecule, and a complex containing said aptamer nucleic acid molecule and a small fluorophore molecule; the aptamer nucleic acid molecule is used for detecting RNA, DNA, or other target molecules inside or...  
WO/2020/221217A1
A fluorescent dye, a preparation method therefor, and a use thereof; the fluorescent dye is sensitive and specific to viscosity response, has the advantage of low background fluorescence, and can be used as a fluorescence activated dot l...  
WO/2020/212583A1
This invention relates to a process for producing cyanoacetates using a cyanoacetamide as a precursor.  
WO/2020/212543A1
The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive unit, said polymerized compounds, and special monomer compounds being particularly suitable for compositions and ophthalm...  
WO/2020/212584A1
This invention relates to a process for producing cyanoacetates using asparagine as a precursor to cyanoacetamide, a staring material to form the cyanoacetates.  
WO/2020/214853A1
The present disclosure provides certain tetrahydro-lH-cyclopenta[cd]indene compounds that are Hypoxia Inducible Factor 2α (HIF-2α) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of HIF-2α. Al...  
WO/2020/213361A1
The present invention pertains to a catalyst that includes molybdenum, bismuth, iron, and nickel, wherein the ratio of surface nickel concentration to bulk nickel concentration is 0.60-1.20.  
WO/2020/212585A1
This invention relates to a process for producing cyanoacetates using aspartic acid as a precursor.  
WO/2020/212872A1
There is provided a metal or metal-ion battery comprising an aluminum current collector and a low-corrosiveness non-aqueous electrolyte comprising, as a solvent, a carbonate compound of formula (I): (I). This battery has an upper voltage...  
WO/2020/213362A1
A catalyst that comprises Mo, Bi, and Fe and satisfies the requirements 0.10

WO/2020/199079A1
Provided are a novel conjugated triene compound 1, a preparation method therefor and use thereof. The conjugated triene compound 1 is obtained by successively subjecting a 2-(cyclohexenylene) malonic acid derivative compound as a raw mat...  
WO/2020/200290A1
Disclosed is a meta-diamide compound and an application thereof. The structure of the compound is represented by general formula I. The definition of each substituent in the formula is provided in the specification. The compound represen...  
WO/2020/200952A1
The present invention pertains to a process for preparing 3-hydroxy-3-methylbutyrate (HMB) or a salt thereof, the method comprising (a) reacting isobutylene oxide with cyanide in order to obtain 3- hydroxy-3-methylbutyronitrile, and (b) ...  
WO/2020/199081A1
The present invention provides a method for preparing a 2-arylmalonic acid derivative, an intermediate, and an application thereof. In the method, a cyclohexadiene compound is taken as a raw material, and isomerization reaction, halogena...  
WO/2020/199078A1
Provided by the present invention are a novel halogenated conjugated diene compound 1, a preparation method therefor and use thereof. The compound 1 can be obtained by subjecting a conjugated diene compound as a raw material to halogenat...  
WO/2020/205470A1
The present disclosure provides compounds and methods for inhibiting or degrading the N-terminal domain of the androgen receptor, as well as methods for treating cancers such as prostate cancer.  
WO/2020/203581A1
A method for producing a nitrile compound, comprising: a first step for introducing, into a reactor, a material gas that includes a cyclic compound having an organic substituent, ammonia and air, and generating a nitrile compound by reac...  
WO/2020/197875A1
The disclosure provides processes for preparing a compound of formula I, comprising reacting a compound of formula II with an aqueous acid in a solvent and at a temperature sufficient for at least about 48 hours to produce a compound of ...  
WO/2020/193387A1
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as fungicides.  
WO/2020/192348A1
Disclosed are phenyl allylidene cyclohexenone derivatives with the structure shown in general formula I. In combination with structural characteristics and structure-function relationship of piplartine, amino bonds are replaced with doub...  
WO/2020/185420A1
Provided herein are integrated methods and systems for the production of acrylamide and acrylonitrile compounds and other compounds from at least beta-lactones and/or beta-hydroxy amides.  
WO/2020/184330A1
A catalyst for acrylonitrile synthesis, which contains a composite body of a metal oxide and a silica that supports the metal oxide, and which is configured such that the ratio of the specific surface area B of the catalyst for acrylonit...  
WO/2020/179671A1
This invention provides: a curable resin composition including a specific polymer precursor, a nonionic compound B, and at least one compound selected from the group consisting of a polymerizable compound and a photosensitive compound, w...  

Matches 1 - 50 out of 22,270